SG3 Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,000
Closed -$594K 62
2022
Q4
$594K Buy
+12,000
New +$490K 0.09% 107
2022
Q2
Sell
-1,000
Closed -$53.5K 534
2022
Q1
$70K Buy
+1,000
New +$73.1K ﹤0.01% 858

Other funds holding EXAS

SG3 Management's EXAS Position: Q1 2023 in Review

SG3 Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 12,000 shares — an estimated $594K sold.

SG3 Management first reported a position in EXAS in Q1 2022 and held it in 2 quarters. The position peaked at $594K in Q4 2022. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • SG3 Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • SG3 Management sold 12,000 Exact Sciences shares in Q1 2023, an estimated $594K.
  • SG3 Management first reported a position in Exact Sciences in Q1 2022 and held it in 2 quarters.
  • SG3 Management's Exact Sciences position peaked at $594K in Q4 2022.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on SG3 Management's 13F filing for Q1 2023, filed 15 May 2023.